Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Home›Research›Companies

Companies

Loading
Home›
Research›
Companies›
GMJ Technologies
AddedFeb 16, 2024
UpdatedJun 18, 2026
GMJ Technologies

GMJ Technologies

Pre-Seed

GMJ Technologies: Pioneering micro-analytical solutions for biopharmaceutical and biomedical sectors.

HQ
Seattle, WA, US
Founded
2018
Overview
Compare
Fundraising
Employees
Website

Founded with a vision to revolutionize the biopharmaceutical and biomedical sectors, GMJ Technologies is an early-stage company specializing in micro-analytical technologies. Their core mission is to develop fast, high-performance, and easy-to-use analytical solutions that enhance productivity in proteomics and protein-drug characterization. The company's innovative products are designed to streamline analytical workflows, providing robust tools for life science applications.

GMJ Technologies has garnered attention for its unique capabilities in protein characterization, significantly impacting the efficiency of analytical processes in the life sciences. The company boasts a team of experts dedicated to advancing micro-analytical technologies. While specific investors and notable affiliated individuals are not disclosed, GMJ Technologies' rapid development and market focus position it as a promising player in the biopharmaceutical and biomedical fields.

GMJ Technologies - Similar Companies

Glyphic Biotechnologies logo

Glyphic Biotechnologies

glyphic.bio

Attometrics logo

Attometrics

Qatch Technologies logo

Qatch Technologies

qatchtech.com

BioAnalytics logo

BioAnalytics

Protein Dynamic Solutions logo

Protein Dynamic Solutions

pdsbio.com

IonDX logo

IonDX

iondx.com

Range Biotechnologies logo

Range Biotechnologies

range.bio

Cytomics Analytical logo

Cytomics Analytical

RedShift BioAnalytics logo

RedShift BioAnalytics

redshiftbio.com

GPB Scientific logo

GPB Scientific

Analiza logo

Analiza

analiza.com

Zymeron logo

Zymeron

zymeron.com

Andson Biotech logo

Andson Biotech

andsonbiotech.com

Genemod logo

Genemod

genemod.net

ProForma Labs logo

ProForma Labs

proformalabs.com

GMJ Technologies - Quick Facts

Who are GMJ Technologies' competitors?

Companies similar to GMJ Technologies include Glyphic Biotechnologies, Attometrics, Qatch Technologies and BioAnalytics.

When was GMJ Technologies founded?

GMJ Technologies was founded in 2018.

Where is GMJ Technologies' headquarters located?

GMJ Technologies' headquarters is located in Seattle, WA, US.

When was GMJ Technologies' last funding round?

GMJ Technologies' most recent funding round was for $1.2M (USD) in January 2021.

How much has GMJ Technologies raised to-date?

As of Jan 28, 2021, GMJ Technologies has raised a total of $1.4M (USD).

How many employees does GMJ Technologies have?

GMJ Technologies has 30 employees as of Feb 4, 2024.

GMJ Technologies - Classification

Ownership
  • Private
Technology
  • Analytics
Geographic Exposure
  • Global
Revenue
  • Recurring
  • Software
Customer
  • Enterprise
Main Product
  • Analytical Solutions
Tags
  • Biotech
NAICS
  • 540000Professional, Scientific, and Technical Services
  • 541500Computer Systems Design and Related Services
  • 541000Professional, Scientific, and Technical Services
  • 541510Computer Systems Design and Related Services
  • 541511Custom Computer Programming Services
SIC
  • 7300Business Services
  • 7370Computer Programming, Data Processing, And Other Computer Related
  • 7371Computer Programming Services
Show 5 more industry codes
NAICS
  • 513200Software Publishers
  • 510000Information
  • 513000Publishing Industries
  • 513210Software Publishers
SIC
  • 7372Prepackaged Software